These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 36334289)

  • 21. Vasculotide restores the blood-brain barrier after focused ultrasound-induced permeability in a mouse model of Alzheimer's disease.
    Lynch M; Heinen S; Markham-Coultes K; O'Reilly M; Van Slyke P; Dumont DJ; Hynynen K; Aubert I
    Int J Med Sci; 2021; 18(2):482-493. PubMed ID: 33390817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood-brain barrier opening with focused ultrasound in Parkinson's disease dementia.
    Gasca-Salas C; Fernández-Rodríguez B; Pineda-Pardo JA; Rodríguez-Rojas R; Obeso I; Hernández-Fernández F; Del Álamo M; Mata D; Guida P; Ordás-Bandera C; Montero-Roblas JI; Martínez-Fernández R; Foffani G; Rachmilevitch I; Obeso JA
    Nat Commun; 2021 Feb; 12(1):779. PubMed ID: 33536430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-lasting restoration of memory function and hippocampal synaptic plasticity by focused ultrasound in Alzheimer's disease.
    Kong C; Ahn JW; Kim S; Park JY; Na YC; Chang JW; Chung S; Chang WS
    Brain Stimul; 2023; 16(3):857-866. PubMed ID: 37211337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Focused ultrasound as a non-invasive method with therapeutic potential in patients with Alzheimer's disease].
    Kovalenko EA; Makhnovich EV; Osinovskaya NA; Bogolepova AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(10):38-45. PubMed ID: 36279227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A sporadic Alzheimer's blood-brain barrier model for developing ultrasound-mediated delivery of Aducanumab and anti-Tau antibodies.
    Wasielewska JM; Chaves JCS; Johnston RL; Milton LA; Hernández D; Chen L; Song J; Lee W; Leinenga G; Nisbet RM; Pébay A; Götz J; White AR; Oikari LE
    Theranostics; 2022; 12(16):6826-6847. PubMed ID: 36276649
    [No Abstract]   [Full Text] [Related]  

  • 26. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
    Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
    Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of focused ultrasound-induced blood-brain barrier permeability in a mouse model of Alzheimer's disease using two-photon microscopy.
    Burgess A; Nhan T; Moffatt C; Klibanov AL; Hynynen K
    J Control Release; 2014 Oct; 192():243-8. PubMed ID: 25107692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrasound-mediated augmented exosome release from astrocytes alleviates amyloid-β-induced neurotoxicity.
    Deng Z; Wang J; Xiao Y; Li F; Niu L; Liu X; Meng L; Zheng H
    Theranostics; 2021; 11(9):4351-4362. PubMed ID: 33754065
    [No Abstract]   [Full Text] [Related]  

  • 29. FUS-mediated blood-brain barrier disruption for delivering anti-Aβ antibodies in 5XFAD Alzheimer's disease mice.
    Antoniou A; Stavrou M; Evripidou N; Georgiou E; Kousiappa I; Koupparis A; Papacostas SS; Kleopa KA; Damianou C
    J Ultrasound; 2024 Jun; 27(2):251-262. PubMed ID: 37516718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinically approved IVIg delivered to the hippocampus with focused ultrasound promotes neurogenesis in a model of Alzheimer's disease.
    Dubey S; Heinen S; Krantic S; McLaurin J; Branch DR; Hynynen K; Aubert I
    Proc Natl Acad Sci U S A; 2020 Dec; 117(51):32691-32700. PubMed ID: 33288687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood-brain barrier opening in Alzheimer's disease using MR-guided focused ultrasound.
    Lipsman N; Meng Y; Bethune AJ; Huang Y; Lam B; Masellis M; Herrmann N; Heyn C; Aubert I; Boutet A; Smith GS; Hynynen K; Black SE
    Nat Commun; 2018 Jul; 9(1):2336. PubMed ID: 30046032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety, Efficacy and Clinical Applications of Focused Ultrasound-Mediated Blood Brain Barrier Opening in Alzheimer's Disease: A Systematic Review.
    Patwardhan A; Wilkinson T; Meng Y; Alhashyan I; Black SE; Lipsman N; Masellis M
    J Prev Alzheimers Dis; 2024; 11(4):975-982. PubMed ID: 39044508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Focused ultrasound-mediated noninvasive blood-brain barrier modulation: preclinical examination of efficacy and safety in various sonication parameters.
    Shin J; Kong C; Cho JS; Lee J; Koh CS; Yoon MS; Na YC; Chang WS; Chang JW
    Neurosurg Focus; 2018 Feb; 44(2):E15. PubMed ID: 29385915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood-brain barrier breakdown in dementia with Lewy bodies.
    Gan J; Xu Z; Chen Z; Liu S; Lu H; Wang Y; Wu H; Shi Z; Chen H; Ji Y
    Fluids Barriers CNS; 2024 Sep; 21(1):73. PubMed ID: 39289698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies targeted to the brain with image-guided focused ultrasound reduces amyloid-beta plaque load in the TgCRND8 mouse model of Alzheimer's disease.
    Jordão JF; Ayala-Grosso CA; Markham K; Huang Y; Chopra R; McLaurin J; Hynynen K; Aubert I
    PLoS One; 2010 May; 5(5):e10549. PubMed ID: 20485502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abundance of P-Glycoprotein and Other Drug Transporters at the Human Blood-Brain Barrier in Alzheimer's Disease: A Quantitative Targeted Proteomic Study.
    Storelli F; Billington S; Kumar AR; Unadkat JD
    Clin Pharmacol Ther; 2021 Mar; 109(3):667-675. PubMed ID: 32885413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Focused ultrasound-induced blood-brain barrier opening improves adult hippocampal neurogenesis and cognitive function in a cholinergic degeneration dementia rat model.
    Shin J; Kong C; Lee J; Choi BY; Sim J; Koh CS; Park M; Na YC; Suh SW; Chang WS; Chang JW
    Alzheimers Res Ther; 2019 Dec; 11(1):110. PubMed ID: 31881998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced delivery of a low dose of aducanumab via FUS in 5×FAD mice, an AD model.
    Kong C; Yang EJ; Shin J; Park J; Kim SH; Park SW; Chang WS; Lee CH; Kim H; Kim HS; Chang JW
    Transl Neurodegener; 2022 Dec; 11(1):57. PubMed ID: 36575534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood-Brain Barrier, Is Compromised in Patients with Mild Alzheimer Disease.
    Deo AK; Borson S; Link JM; Domino K; Eary JF; Ke B; Richards TL; Mankoff DA; Minoshima S; O'Sullivan F; Eyal S; Hsiao P; Maravilla K; Unadkat JD
    J Nucl Med; 2014 Jul; 55(7):1106-11. PubMed ID: 24842892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment.
    Lin KJ; Hsiao IT; Hsu JL; Huang CC; Huang KL; Hsieh CJ; Wey SP; Yen TC
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1304-14. PubMed ID: 27003417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.